EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans. - Wikidata - awgldk - TriplyDB

EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans.

EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans.

http://www.wikidata.org/entity/Q34457573

about

The reticulons: a family of proteins with diverse functions Glial inhibition of CNS axon regeneration The Extract of Roots of Sophora flavescens Enhances the Recovery of Motor Function by Axonal Growth in Mice with a Spinal Cord Injury.The role of cyclic AMP signaling in promoting axonal regeneration after spinal cord injury Inhibition of EGFR/MAPK signaling reduces microglial inflammatory response and the associated secondary damage in rats after spinal cord injury Image-based compound profiling reveals a dual inhibitor of tyrosine kinase and microtubule polymerization Stem cell transplantation for auditory nerve replacement Localized alteration of microtubule polymerization in response to guidance cues.Integrity of cortical perineuronal nets influences corticospinal tract plasticity after spinal cord injury.In-vivo single neuron axotomy triggers axon regeneration to restore synaptic density in specific cortical circuits.Roles of PI3K and JAK pathways in viability of retinal ganglion cells after acute elevation of intraocular pressure in rats with different autoimmune backgrounds.Stimulating neuroregeneration as a therapeutic drug approach for traumatic brain injury.A chemical screen identifies novel compounds that overcome glial-mediated inhibition of neuronal regeneration.Traumatic brain injury results in disparate regions of chondroitin sulfate proteoglycan expression that are temporally limited Bone Marrow-Derived Mesenchymal Stem Cells-Derived Exosomes Promote Survival of Retinal Ganglion Cells Through miRNA-Dependent Mechanisms.Kappa opioid receptor contributes to EGF-stimulated neurite extension in development CSPG is a secreted factor that stimulates neural stem cell survival possibly by enhanced EGFR signaling.Neurotrophic effect of a novel TrkB agonist on retinal ganglion cells.TGF-alpha increases astrocyte invasion and promotes axonal growth into the lesion following spinal cord injury in mice.Peripheral nervous system genes expressed in central neurons induce growth on inhibitory substrates.Decorin treatment of spinal cord injury Optic neuropathy due to microbead-induced elevated intraocular pressure in the mouse.AMIGO3 is an NgR1/p75 co-receptor signalling axon growth inhibition in the acute phase of adult central nervous system injury.An in vitro assay to study induction of the regenerative state in sensory neurons.Treatment with Anti-EGF Ab Ameliorates Experimental Autoimmune Encephalomyelitis via Induction of Neurogenesis and Oligodendrogenesis Nanospheres delivering the EGFR TKI AG1478 promote optic nerve regeneration: the role of size for intraocular drug delivery.Extracellular regulators of axonal growth in the adult central nervous system NG2+ progenitors derived from embryonic stem cells penetrate glial scar and promote axonal outgrowth into white matter after spinal cord injury Transforming growth factor α transforms astrocytes to a growth-supportive phenotype after spinal cord injury A disintegrin and metalloprotease 17 promotes microglial cell survival via epidermal growth factor receptor signalling following spinal cord injury.Nanoparticle-mediated signaling endosome localization regulates growth cone motility and neurite growth.Neuroglobin is an endogenous neuroprotectant for retinal ganglion cells against glaucomatous damage.Fibrinogen inhibits neurite outgrowth via beta 3 integrin-mediated phosphorylation of the EGF receptor The yellow fluorescent protein (YFP-H) mouse reveals neuroprotection as a novel mechanism underlying chondroitinase ABC-mediated repair after spinal cord injury.The roles of neuronal and glial precursors in overcoming chondroitin sulfate proteoglycan inhibition A chemical genetic approach identifies piperazine antipsychotics as promoters of CNS neurite growth on inhibitory substrates.Modifying effect of intravenous laser therapy on the protein expression of arginase and epidermal growth factor receptor in type 2 diabetic patients.Indomethacin protects rats from neuronal damage induced by traumatic brain injury and suppresses hippocampal IL-1β release through the inhibition of Nogo-A expression.Successive distinct high-grade gliomas in L-2-hydroxyglutaric aciduria.Microglial TIR-domain-containing adapter-inducing interferon-β (TRIF) deficiency promotes retinal ganglion cell survival and axon regeneration via nuclear factor-κB.

P2860

Q21184131-331C0AD6-4D29-4F37-B3D0-83C3914E2805 Q24648851-6A9C0C99-9D2F-4A76-BADE-0875DDCEC09E Q27308067-AD3DE7CB-5CC3-40EF-B816-34B31D919EFD Q28242237-978F872C-B9B6-4B33-879E-EB7F4175BCE1 Q28574797-8887A02B-CA89-49F1-9015-F25A1B84E3E8 Q28834113-4B73102D-8717-4090-825A-6894D11AF6AA Q30487720-EEED6545-1056-43F5-A7BC-B00245BA5F0B Q30496825-E9FE0CEF-B487-4CFA-B26A-DBCCBB340026 Q30621527-375CD546-A2BB-424B-9001-72F17D3502CB Q31121560-D485AA8B-43C5-4422-8ED2-838B1064C231 Q33359006-7B4D8558-A95E-41D6-A170-210435E4388B Q33440801-FF2EECF0-0067-4713-9BF2-5F34C6AF69AB Q33548229-30CBAEF9-CEA0-4E2C-95CD-CD9E5E7A602F Q33649452-91D0A7C1-2BB3-42D6-B4BB-0A562EA4706A Q33722613-AE4F60B0-AB48-4B8D-949E-7C8078F677DC Q33733621-5E753458-F1A7-4F82-B5F2-581B36FEBB60 Q33778597-5660CE1B-9306-43C8-B14D-5D78D8DC21CF Q33845125-EFC5D488-9AFE-4710-B32D-A9F8AACEC808 Q33956900-5D479F0F-60A8-4854-A8D7-DAF704B21A3B Q34305326-4593F740-7BBB-4FEB-8B80-22ACD4E40B10 Q34412717-B4CFE99E-13B8-4658-AB63-86AE0C9A24F9 Q34646704-C3A9AE10-1BBF-43C7-A523-DA2ACCF995E8 Q34685351-AF5DB2E6-7734-4396-86B8-4F4F63332AB5 Q34702291-D02A8407-DE0D-4D94-A06A-08746E027BA2 Q34970564-8D33711F-A71D-4608-AE96-4A1037D84C56 Q35105415-2B05358B-60DA-4A77-966B-6D20A9BFB584 Q35172113-EED93FD3-D8AE-4125-8F93-17CB5B84A917 Q35200151-96E5B240-A8A2-411A-AB29-08F13CB86E1E Q35543006-5111F5D9-5506-42FF-BAB8-1538BE81F349 Q35571359-84D9068B-5920-42FB-A769-D87A756F3ABE Q35571399-1B1966FA-BB26-44CF-9801-026011D83EE4 Q35679417-ED488EBA-DFBF-48BA-9D45-2224FD7BDF15 Q35880183-B09AF599-BC75-407E-9F84-129F1457E066 Q35923626-CB7740BD-E099-4032-8BD9-7EC4977A4E6B Q35936091-0C0F2BDE-748B-4424-900C-B6C648EFF365 Q36059047-0A138349-5E00-4B3D-A200-5C54CE90577C Q36074410-4F9CAAF4-8C46-4A57-9CE4-DA2BA2F6218C Q36156649-3A874331-0B58-4678-9AA3-63E1903F2390 Q36311724-CABC2DF5-ED04-4E48-9CB6-8E6F38CC196F Q36317535-7F41D444-FF04-4336-A06E-4CA6F6A02AC7

P2860

EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans.

http://www.wikidata.org/entity/Q34457573

description

2005 nî lūn-bûn

@nan

2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

EGFR activation mediates inhib ...... droitin sulfate proteoglycans.

@ast

EGFR activation mediates inhib ...... droitin sulfate proteoglycans.

@en

EGFR activation mediates inhib ...... droitin sulfate proteoglycans.

@nl

type

label

EGFR activation mediates inhib ...... droitin sulfate proteoglycans.

@ast

EGFR activation mediates inhib ...... droitin sulfate proteoglycans.

@en

EGFR activation mediates inhib ...... droitin sulfate proteoglycans.

@nl

prefLabel

EGFR activation mediates inhib ...... droitin sulfate proteoglycans.

@ast

EGFR activation mediates inhib ...... droitin sulfate proteoglycans.

@en

EGFR activation mediates inhib ...... droitin sulfate proteoglycans.

@nl

P1433

Q34457573-74597472-FF6B-4211-AEDE-E5E0C66CAF8E

P1476

Q34457573-2332D6DD-2450-4F32-BC5F-3769DA93FC60

P2093

Q34457573-2BF2789D-3BA5-4C50-A5C3-CAD055068F64

Q34457573-87A87A50-406D-4278-8074-F9258A21245B

Q34457573-9EE5BDDA-D9F1-444D-9B35-EF2FAB338322

Q34457573-A2344905-D1F6-4168-97AC-087149DA0FDE

Q34457573-AC20FCB6-0F4D-4228-99AF-E33F5678D436

Q34457573-DE6BFE04-A763-428E-811E-8F4193045FE8

Q34457573-E768E19D-1DCF-42A1-A099-C14F4DADB2DF

Q34457573-EA905B7E-5570-43D2-9162-C3955F91CCB2

Q34457573-F1BDD726-4CBA-4149-8319-40AD7B3289DA

Q34457573-F6EC5F1E-8297-4C9E-971A-1CB34FA5762C

P304

Q34457573-238F5AD9-CA27-4F60-9166-83AE9475BF64

P31

Q34457573-CCB6A999-7623-4872-964E-76849C951A6E

P356

Q34457573-46720179-2115-40BC-97BB-C8BE581180D2

P407

Q34457573-77D599B6-CB09-4FBE-8D2E-EFE48250AE01

P433

Q34457573-707D4042-0A5A-4781-B299-6FC6E053B5AC

P478

Q34457573-E70622CC-587C-4BD7-A3BF-470CEE05E2F9

P577

Q34457573-491AD379-3FA5-46A4-817F-68F4878F6E78

P698

Q34457573-46987FF5-DAAB-4FA7-BF21-158C306D3A27

P356

SCIENCE.1115462

P1433

P1476

EGFR activation mediates inhib ...... droitin sulfate proteoglycans.

@en

P2093

Bryan Gore

http://www.w3.org/2001/XMLSchema#string

Dong Feng Chen

http://www.w3.org/2001/XMLSchema#string

Estelle Lin

http://www.w3.org/2001/XMLSchema#string

Glenn Yiu

http://www.w3.org/2001/XMLSchema#string

Jasvinder Atwal

http://www.w3.org/2001/XMLSchema#string

Jieun A Kim

http://www.w3.org/2001/XMLSchema#string

Jong Bae Park

http://www.w3.org/2001/XMLSchema#string

Kin-Sang Cho

http://www.w3.org/2001/XMLSchema#string

Marc Tessier-Lavigne

http://www.w3.org/2001/XMLSchema#string

Vuk Koprivica

http://www.w3.org/2001/XMLSchema#string

P304

106-110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.1115462

http://www.w3.org/2001/XMLSchema#string

P407

P433

5745

http://www.w3.org/2001/XMLSchema#string

P478

310

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16210539

http://www.w3.org/2001/XMLSchema#string